Even though it is known that neurofibromatosis patients have a significantly increased breast cancer risk and that NF1 is mutated in sporadic breast cancers, the impact of NF1 deficiency and RAS deregulation in sporadic breast cancer is often overlooked. The gene discussed is NF1; the disease is breast cancer.